New Delhi: The country will soon get another vaccine of Corona. Today DGCI has allowed Cipla to import Moderna’s COVID-19 vaccine for limited emergency use in India.
The notice stated that if the vaccine is permitted by the US Food and Drug Administration (USFDA) for Emergency Use Authorization (EUA), the vaccine will not be allowed to undergo a ‘bridging trial’. Marketing rights can be given. In addition, each consignment may be exempted from the need for testing from the Central Drugs Laboratory (CDL), Kasali.